Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on September 24, 2025. The filing serves as a Regulation FD disclosure to announce an upcoming Investor Day scheduled for September 24, 2025, at 9:00 a.m. Eastern time in New York City.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding an investor event and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the scheduling of a corporate event.
Guidance, Outlook, and Management Commentary
Management, including co-Chief Executive Officers Helmy Eltoukhy and AmirAli Talasaz, will present updates on the Company's operations, key strategic priorities, and financial outlook during the Investor Day. The presentation will be available via live and archived webcast on the Company's website. The filing explicitly states that the information provided is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Event Date: September 24, 2025.
- Event Time: 9:00 a.m. Eastern time.
- Location: New York City (with webcast access).
- Key Speakers: Helmy Eltoukhy and AmirAli Talasaz (co-CEOs).
- Content Focus: Operational updates, strategic priorities, and financial outlook.
- Access: Live and archived webcast available at www.guardanthealth.com.